Raymond Lau Family Medicine PC | Primary Care | Weight Loss

Raymond Lau Family Medicine PC operates as a primary care practice in New York, NY, integrating medical weight loss therapies into comprehensive adult healthcare. Dr. Raymond Lau leads the practice with a focus on evidence-based interventions for metabolic health, offering GLP-1 receptor agonist peptides as part of structured weight management programs. The practice serves patients seeking both routine primary care and targeted obesity treatment within a single clinical relationship, eliminating the need for separate specialist referrals for weight-related conditions.

The clinic prescribes Semaglutide and Tirzepatide for patients meeting clinical criteria for medical weight loss therapy. Semaglutide, a GLP-1 agonist, works by regulating appetite signals and slowing gastric emptying, while Tirzepatide combines GLP-1 and GIP receptor activity for dual incretin effect. Dr. Lau evaluates patients for contraindications, establishes baseline metabolic panels, and monitors thyroid function and cardiovascular markers throughout treatment. Dosing follows FDA-approved titration schedules, with adjustments based on individual tolerance and response. Patients receive education on injection technique, side effect management, and the importance of concurrent lifestyle modification for sustained results beyond peptide therapy.

Dr. Raymond Lau brings primary care expertise to weight management, understanding how obesity intersects with hypertension, prediabetes, dyslipidemia, and other chronic conditions commonly managed in family medicine. His approach addresses weight loss not as an isolated cosmetic goal but as a component of comprehensive metabolic health optimization. The practice maintains continuity of care, allowing Dr. Lau to adjust peptide protocols in response to changes in other medications, lab values, or comorbid conditions. This integrated model proves particularly valuable for patients whose weight contributes to multiple health issues requiring coordinated management.

Patients at Raymond Lau Family Medicine PC in New York typically begin with an initial consultation that includes medical history review, physical examination, and laboratory assessment to determine candidacy for peptide therapy. The practice schedules follow-up visits at intervals appropriate to the titration phase and individual patient needs, with telehealth options available for routine monitoring visits. Dr. Lau's communication style, noted in patient feedback for its clarity and approachability, facilitates open discussion about weight loss expectations, potential side effects like nausea or gastrointestinal changes, and strategies for maintaining results. The practice provides clear instructions for medication storage, administration, and when to contact the office with concerns.

Located in New York, NY, the practice offers accessibility for Manhattan residents seeking medical weight loss without the overhead of specialized obesity clinics. Raymond Lau Family Medicine PC accepts various insurance plans for primary care services, though patients should verify coverage specifics for GLP-1 peptide medications, which vary by insurer and policy. The practice's dual focus allows patients to address weight management alongside preventive care, chronic disease management, and acute illness treatment in a familiar clinical setting. Dr. Lau's model demonstrates how primary care practices can effectively incorporate peptide therapies when providers pursue appropriate training and maintain protocols for safe prescribing and monitoring.